US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Avalon GloboCare Corp. - Common Stock
(NQ:
AVCO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 9, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avalon GloboCare Corp. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 30, 2021
Gainers BioLine Rx (NASDAQ:BLRX) stock i...
Via
Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
June 21, 2021
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)...
From
Halper Sadeh LLP
Via
AccessWire
Topics
Fraud
Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVCO
June 14, 2021
From
Halper Sadeh LLP
Via
Business Wire
Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights
↗
June 14, 2021
Avalon GloboCare Corp (NASDAQ: AVCO) has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 18, 2021
Gainers Lixte Biotech Holdings (NASDAQ:LIXT
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
May 10, 2021
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
April 16, 2021
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Yatsen Holding (NYSE:...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
April 13, 2021
Tuesday morning, 38 companies set new 52-week lows. Key Facts: Viatris (NASDAQ:VTRS) was the largest company by market cap to set a new 52-week low. Enservco (AMEX:...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 08, 2021
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica Therapeutics's trading volume hit 12.0K...
Via
Benzinga
< Previous
1
2
3
Next >
